Alejandro Ruíz-Patiño

Author

Foundation for Clinical and Applied Cancer Research ORCID

Also Known As

A. Ruiz-Patino, A. Ruiz-Patiño, ALEJANDRO RUIZ-PATIÑO, Alejandro Ruiz Patiño, Alejandro Ruiz-Patiño, Alejandro Ruiz-Patiño, Alejandro Ruiz‐Patiño, Alejandro Ruíz-Patiño

127

Publications

Citations

H-Index

Concepts

All Affiliations

Foundation for Clinical and Applied Cancer Research Instituto Nacional de Cancerología Universidad El Bosque Instituto Alexander Fleming Fundación Universitaria Sanitas

About

Alejandro Ruíz-Patiño is an author at Foundation for Clinical and Applied Cancer Research specializing in medicine, pathology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	259
2	Cell Biology	1	1	33
3	Emergency Medicine	1	1	16
4	Health Management	1	1	16
5	Health Policy	1	1	29

Alejandro Ruíz-Patiño

Publications

605

Citations

H-Index

Page 1

	Year	Citations
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP) Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Lung Cancer Tumor BiologyMedicinePathologyBronchial NeoplasmMolecular Oncology	2018	60
Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP) Alejandro Ruíz-Patiño, Óscar Arrieta, Andrés F. Cardona, Thoracic Cancer	2019	60
Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma Andrés F. Cardona, Leonardo Rojas, Beatriz Wills, Journal of Neuro-Oncology Neuro-oncologyMedicineHispanic PatientsOther Antiepileptic DrugsPsychotropic Medication	2017	43
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation Andrés F. Cardona, Daniel Jaramillo-Velásquez, Alejandro Ruíz-Patiño, Journal of Neuro-Oncology Egfrviii MutationNeuro-oncologySimultaneous Egfr AmplificationOncologyGlioma	2021	43
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) Vladmir Cláudio Cordeiro de Lima, Marcelo Corassa, Erick Figueiredo Saldanha, Lung Cancer	2022	39
EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP) Alejandro Ruíz-Patiño, Christian David Castro, Luisa Ricaurte, Targeted Oncology MedicinePathologySensitizing Mutations CorrelateBronchial NeoplasmCancer Genomics	2018	33
Cost-effectiveness of laparoscopic versus open appendectomy in developing nations: a Colombian analysis Alejandro Ruíz-Patiño, Samuel Rey, Germán Molina, Journal of Surgical Research LaparoscopyHealth PolicyHealth EconomicsSurgical SafetyOutcomes Research	2017	29
Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib Andrés F. Cardona, Alejandro Ruíz-Patiño, Zyanya Lucía Zatarain-Barrón, PLoS ONE	2019	29
Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP) Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Frontiers in Oncology	2019	26
Probable hereditary familial overlap syndrome with multiple synchronous lung tumors Andrés F. Cardona, Zyanya Lucía Zatarain-Barrón, Cladelis Rubio, Lung Cancer Genetic DisorderGeneticsGenetic EpidemiologyPathologyBronchial Neoplasm	2018	23

Page 1